Acro Biomedical Co., Ltd. (ACBM) financial statements (2020 and earlier)

Company profile

Business Address 12175 VISIONARY WAY
FISHERS, IN 46038
State of Incorp. NV
Fiscal Year End September 30
SIC 79 - Amusement And Recreation Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
Q4
6/30/2019
Q3
3/31/2019
Q2
12/31/2018
Q1
9/30/2018
Q4
6/30/2018
Q3
3/31/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1003815472
Cash and cash equivalents1003815472
Inventory, net of allowances, customer advances and progress billings1,0601,0601,0603601,147900301
Inventory1,0601,0601,0603601,147900301
Prepaid expense3691483308191
Deposits current assets5555   
Other undisclosed current assets   700 20 
Total current assets:1,0691,0711,0741,2511,4781,005863
Noncurrent Assets
Deferred tax assets, net106520   
Other undisclosed noncurrent assets    555
Total noncurrent assets: 106520555
TOTAL ASSETS:1,0691,0811,1391,2711,4831,010868
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:18101187418
Taxes payable  9292928829
Other undisclosed accounts payable and accrued liabilities1810(82)(85)(85)(85)(10)
Due to related parties6210318314114095
Deferred revenue and credits65
Other undisclosed current liabilities1162011292928829
Total current liabilities:196133141103241233207
Noncurrent Liabilities
Total liabilities:196133141103241233207
Stockholders' equity
Stockholders' equity attributable to parent8749489981,1681,242777661
Common stock48484848484848
Additional paid in capital871870870870869558558
Retained earnings (accumulated deficit)(45)308125032517255
Total stockholders' equity:8749489981,1681,242777661
TOTAL LIABILITIES AND EQUITY:1,0691,0811,1391,2711,4831,010868

Income statement (P&L) ($ in thousands)

9/30/2019
Q4
6/30/2019
Q3
3/31/2019
Q2
12/31/2018
Q1
9/30/2018
Q4
6/30/2018
Q3
3/31/2018
Q2
Revenues   1,3542,4072,1991,964
Cost of revenue   (1,219)(2,154)(1,959)(1,768)
Gross profit:   135253240196
Operating expenses(64)(68)(215)(230)(92)(64)(98)
Operating income (loss):(64)(68)(215)(94)16117698
Nonoperating expense(1)(1)(0)(1)   
Interest and debt expense(1)(1)(0)(1)   
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes1101(4)  
Income (loss) from continuing operations before income taxes:(65)(69)(215)(95)15717698
Income tax expense (benefit)(10)184520(4)(60)(29)
Net income (loss) available to common stockholders, diluted:(75)(51)(170)(75)15411669

Comprehensive Income ($ in thousands)

9/30/2019
Q4
6/30/2019
Q3
3/31/2019
Q2
12/31/2018
Q1
9/30/2018
Q4
6/30/2018
Q3
3/31/2018
Q2
Net income (loss):(75)(51)(170)(75)15411669
Comprehensive income (loss), net of tax, attributable to parent:(75)(51)(170)(75)15411669

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: